What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine

Smriti Mallapaty and Ewen Callaway

Nature, 2021, vol. 592, issue 7852, 15-17

Abstract: Results confirming the vaccine’s strong protection against COVID-19 were welcomed following last week’s pause in roll-outs — but fresh questions have now emerged about the data.

Keywords: SARS-CoV-2; Vaccines; Infection (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-021-00785-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:592:y:2021:i:7852:d:10.1038_d41586-021-00785-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-021-00785-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().